Publications de Isabelle POIZOT-MARTIN
HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data).
AIDS Research and Therapy
2022
;
19
(1)
Prevalence and Spectrum of Second Primary Malignancies among People Living with HIV in the French Dat’AIDS Cohort.
Cancers
2022
;
14
(2)
:
401.
Kaposi’s Sarcoma in Virally Suppressed People Living with HIV: An Emerging Condition.
Cancers
2021
;
13
(22)
:
5702.
Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C Virus.
Clinical Infectious Diseases
2021
;
72
(9)
:
e215 - e223.
Do people living with HIV face more secondary cancers than general population: From the French CANCERVIH network.
Bulletin du Cancer
2021
;
155
CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies.
Clinical Infectious Diseases
2021
;
73
(1)
:
50-59.
[Survey on HIV, HBV and HCV screening practices in cancerology, France].
Bulletin du Cancer
2021
;
108
(4)
:
369 - 376.
Spectrum and Incidence Trends of AIDS- and Non–AIDS-Defining Cancers between 2010 and 2015 in the French Dat'AIDS Cohort.
Cancer Epidemiology, Biomarkers and Prevention
2021
;
30
(3)
:
554-563.
Is the use of the QPC cognitive complaints questionnaire relevant for the screening strategy of HIV-Associated neurocognitive disorders?
AIDS Care
2021
;
33
(3)
:
389-397.
Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH).
Expert Review of Anti-infective Therapy
2021
;
19
(9)
:
1147-1156.
Microelimination or Not? The Changing Epidemiology of Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in France 2012–2018.
Clinical Infectious Diseases
2021
;
ciaa1940.
Determinants of Second Primary Cancer Type in Survivors of Virus-Related and Non-Virus-Related Cancer Living With HIV in the French Dat’AIDS Cohort.
Cancer Control: Journal of the Moffitt Cancer Center
2021
;
28
:
10732748211066310.
Spectrum and incidence trends of AIDS and non-AIDS defining cancers between 2010-2015 in the French Dat'AIDS cohort.
Cancer Epidemiology, Biomarkers and Prevention
2020
;
cebp.1045.2020.
Life after hepatitis C cure in HIV‐infected people who inject drugs and men who have sex with men treated with direct‐acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH).
Journal of Viral Hepatitis
2020
;
27
(12)
:
1462-1472.
Incidence and Clearance of Anal Human Papillomavirus (HPV)-16 and HPV-18 Infection, and Their Determinants, Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men in France.
Journal of Infectious Diseases
2020
;
221
(9)
:
1488-1493.
Kaposi sarcoma in people living with HIV: incidence and associated factors in a French cohort between 2010 and 2015.
AIDS. Official journal of the international AIDS Society
2020
;
34
(4)
:
569-577.
Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH).
Journal of Hepatology
2020
;
72
(3)
:
588-591.
Hepatitis C virus-microelimination program and patient trajectories after hepatitis C virus cure in an outpatient HIV clinical unit.
European Journal of Gastroenterology & Hepatology
2020
;
1.
Extracellular vesicles from T cells overexpress miR-146b-5p in HIV-1 infection and repress endothelial activation.
Scientific Reports
2019
;
9
(1)
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1.
Antiviral Research
2019
;
170
:
104543.
Recurrence and occurrence of Kaposi’s sarcoma in HIV-infected patients on antiretroviral therapy despite suppressed HIV viremia.
Clinical Infectious Diseases
2019
.
Unsupervised PrEP in routine practice: a new challenge?
International Journal of STD and AIDS
2019
;
30
(7)
:
715-717.
Nadir CD4 Is Negatively Associated With Antinuclear Antibody Detection in HCV/HIV-Coinfected Patients.
Journal of Acquired Immune Deficiency Syndromes - JAIDS
2019
;
80
(4)
:
461-466.
Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study.
PLoS ONE
2019
;
14
(1)
:
e0211286.
Consultation « santé sexuelle et affective » : quelles attentes pour les personnes vivant avec le VIH ?
Sexologies
2019
;
28
(1)
:
20-24.
Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort.
European Journal of Gastroenterology & Hepatology
2019
;
31
(11)
:
1387-1396.
Extracellular vesicles from T cells overexpress miR-146b-5p in HIV-1 infection and repress endothelial activation.
Scientific Reports
2019
;
9
(10299)
Immunotherapy for cancer in people living with HIV: safety with an efficacy signal from the series in real life experience.
AIDS. Official journal of the international AIDS Society
2019
;
33
(11)
:
F13-F19.
Determinants of high-grade anal intraepithelial lesions in HIV-positive men having sex with men.
AIDS. Official journal of the international AIDS Society
2018
;
32
(16)
:
2363-2371.
Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIV.
AIDS. Official journal of the international AIDS Society
2018
;
32
(8)
:
1077-1082.
Prevalence and Risk Factors for Anal Human Papillomavirus Infection in Human Immunodeficiency Virus–Positive Men Who Have Sex with Men.
Journal of Infectious Diseases
2018
;
217
(10)
:
1535-1543.
Ledipasvir and tenofovir drug interaction in human immunodeficiency virus-hepatitis C virus coinfected patients: Impact on tenofovir trough concentrations and renal safety.
British Journal of Clinical Pharmacology
2018
;
84
(2)
:
404-409.
HIV is associated with airway obstruction: a matched controlled study.
AIDS. Official journal of the international AIDS Society
2018
;
32
(2)
:
227-232.
Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients.
PLoS ONE
2018
;
13
(9)
:
e0203895.
Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients.
World journal of hepatology
2018
;
10
(11)
:
856-866.
Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort.
PLoS ONE
2018
;
13
(12)
:
e0208657.
Cancer risk in HIV-infected patients.
AIDS. Official journal of the international AIDS Society
2018
;
32
(5)
:
673-675.
Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination.
BMC Medicine
2017
;
15
(1)
:
217.
Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimen.
Journal of Antimicrobial Chemotherapy
2017
;
3425-3434.
Sub-therapeutic darunavir concentration and garlic consumption; a «Mediterranean» drug-food interaction, about 2 cases.
European Journal of Clinical Pharmacology
2017
;
73
(10)
:
1331-1333.
Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?
Journal of Infection
2017
;
75
(3)
:
234-241.
Pain in methadone patients: Time to address undertreatment and suicide risk (ANRS-Methaville trial).
PLoS ONE
2017
;
12
(5)
:
e0176288.
No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort).
Drug and Alcohol Review
2017
;
36
(2)
:
227-238.
Quality of life improvement in HIV-1 patients treated with raltegravir in a real-life observational study: RACING.
HIV Clinical Trials
2017
;
18
(1)
:
1-16.
Impact of tenofovir dose adjustment on both estimated glomerular filtration rate and tenofovir trough concentration.
Antiviral Therapy
2017
;
22
(6)
:
529-533.
Frailty in HIV infected people: a new risk factor for bone mineral density loss.
AIDS. Official journal of the international AIDS Society
2017
;
31
(11)
:
1573-1577.
Daclatasvir plasma concentration assessment in HIV-HCV-coinfected real-life patients.
Antiviral Therapy
2017
;
22
(8)
:
731-733.
CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART.
PLoS ONE
2016
;
11
(11)
:
e0165774.
Lung Cancer Screening with Chest Computed Tomography in People Living with HIV: A Review by the Multidisciplinary CANCERVIH Working Group.
Journal of Thoracic Oncology
2016
;
11
(10)
:
1644 - 1652.
All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus–coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13–HEPAVIH Cohort.
Clinical Infectious Diseases
2016
;
63
(6)
:
763-770.
Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy.
AIDS. Official journal of the international AIDS Society
2016
;
30
(13)
:
2085--2090.
Prevalence of and Risk Factors for Anal Oncogenic Human Papillomavirus Infection Among HIV-Infected Women in France in the Combination Antiretroviral Therapy Era.
Journal of Infectious Diseases
2016
;
213
(9)
:
1455-1461.
Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group.
Annals of Oncology
2016
;
27
(3)
:
397-408.
Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study).
Harm Reduction Journal
2015
;
13
(1)
:
12.
Suicidal risk among patients enrolled in methadone maintenance treatment: HCV status and implications for suicide prevention (ANRS Methaville).
Comprehensive Psychiatry
2015
;
62
:
123-131.
Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
AIDS. Official journal of the international AIDS Society
2015
;
29
(12)
:
1505 - 1510.
High prevalence of Anal Human Papillomavirus-associated cancer precursors in a contemporary cohort of asymptomatic HIV-infected women.
Clinical Infectious Diseases
2015
;
60
(10)
:
1559-68.
Methadone Induction in Primary Care for Opioid Dependence: A Pragmatic Randomized Trial (ANRS Methaville).
PLoS ONE
2014
;
9
(11)
:
112328 - 112328.
Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions.
Substance Abuse Treatment, Prevention, and Policy
2014
;
9
:
37.
Lopinavir/r no longer recommended as first line regimen: a comparative effectiveness analysis.
Journal of the International AIDS Society
2014
;
17
:
19070.
Impact of HCV treatment and depressive symptoms on adherence to HAART among coinfected HIV-HCV patients: results from the ANRS-CO13-HEPAVIH cohort.
Antiviral Therapy
2014
;
19
(2)
:
171-8.
Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France).
BMC Health Services Research
2012
;
12
(1)
:
59.
OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial.
Retrovirology
2009
;
6
(Suppl 3)
:
O25.